Furst DE - Search Results

1

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.

Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MH, Barr W, Moreland LW, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold JR. Clements PJ, et al. Among authors: furst de. Arthritis Rheum. 1999 Jun;42(6):1194-203. doi: 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7. Arthritis Rheum. 1999. PMID: 10366112 Free article. Clinical Trial.

2

A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?

Furst DE, Clements PJ, Graze P, Gale R, Roberts N. Furst DE, et al. Arthritis Rheum. 1979 Aug;22(8):904-10. doi: 10.1002/art.1780220815. Arthritis Rheum. 1979. PMID: 37843

3

Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma).

Clements PJ, Opelz G, Terasaki PI, Mickey MR, Furst D. Clements PJ, et al. Tissue Antigens. 1978 Apr;11(4):357-61. doi: 10.1111/j.1399-0039.1978.tb01268.x. Tissue Antigens. 1978. PMID: 78536

4

A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis.

Furst DE, Levine S, Srinivasan R, Metzger AL, Bangert R, Paulus HE. Furst DE, et al. Arthritis Rheum. 1977 Nov-Dec;20(8):1473-80. doi: 10.1002/art.1780200805. Arthritis Rheum. 1977. PMID: 144508 Clinical Trial.

5

Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies.

Smith JW, Clements PJ, Levisman J, Furst D, Ross M. Smith JW, et al. Am J Med. 1979 Jan;66(1):28-33. doi: 10.1016/0002-9343(79)90478-9. Am J Med. 1979. PMID: 154294 No abstract available.

6

Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma).

White SC, Frey NW, Blaschke DD, Ross MD, Clements PJ, Furst DE, Paulus HE. White SC, et al. Among authors: furst de. J Am Dent Assoc. 1977 Jun;94(6):1178-82. doi: 10.14219/jada.archive.1977.0367. J Am Dent Assoc. 1977. PMID: 266529

7

Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.

Furst DE, Clements PJ, Harris R, Ross M, Levy J, Paulus HE. Furst DE, et al. Ann Rheum Dis. 1979 Aug;38(4):356-61. doi: 10.1136/ard.38.4.356. Ann Rheum Dis. 1979. PMID: 386962 Free PMC article. Clinical Trial.

8

Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.

Clements PJ, Furst DE, Campion DS, Bohan A, Harris R, Levy J, Paulus HE. Clements PJ, et al. Among authors: furst de. Arthritis Rheum. 1978 Jan-Feb;21(1):62-71. doi: 10.1002/art.1780210111. Arthritis Rheum. 1978. PMID: 623695

9

Why everything (or nothing) seems to work in the treatment of scleroderma.

Seibold JR, Furst DE, Clements PJ. Seibold JR, et al. Among authors: furst de. J Rheumatol. 1992 May;19(5):673-6. J Rheumatol. 1992. PMID: 1613694 No abstract available.

10

Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis.

Clements PJ, Lachenbruch PA, Furst DE, Paulus HE, Sterz MG. Clements PJ, et al. Among authors: furst de. Arthritis Rheum. 1991 Nov;34(11):1371-80. doi: 10.1002/art.1780341105. Arthritis Rheum. 1991. PMID: 1835389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

725 results

Search Page